- recruitingPHASE2
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
This study is looking into a new medication called NEU-411 for people aged 40-80 with early Parkinson's disease. It focuses on those with a specific genetic marker. The aim is to see if the drug is safe and effective in slowing the disease's progress.
United States · Israel · Italy - recruiting
AID-FOG: Artificial Intelligence-Driven Freezing of Gait Detection in the Home
This study looks at using AI and wearable sensors to detect 'Freezing of Gait' (FOG) in people with Parkinson's at home. FOG makes walking difficult and can cause falls. We want to see if our AI technology can spot FOG accurately outside of a clinic.
Belgium · Germany · Israel - not yet recruitingNA
SMART-PD: Evaluating the Impact of Smartphone-Based Wearable Technology on Motor Symptoms and Quality of Life in People With Parkinson's Disease
This study looks at whether smartwatches can help people with Parkinson's better manage their symptoms. It compares regular care to care with a smartwatch and app, hoping to give doctors a clearer picture of how symptoms change throughout the day to improve treatment.
Canada